Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,472
datasets available to search
ShareScore release 0.9.0
Dataset results
1,472 results for “EGFR”
Phase III Trial to Evaluate the Elortinib vs Gefitinib in Advanced NSCLC With EGFR Exon 19 or 21 Mutations
ClinicalTrials.gov study NCT01024413. IPD Sharing: UNDECIDED. Countries: 1. Publications: 14.
Erlotinib in Post Radical Operation NSCLC Patients With EGFR Mutation
ClinicalTrials.gov study NCT01683175. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Study to Evaluate Concordance of Detecting EGFR (Epidermal Growth Factor Receptor) Mutation by Circulating Tumour Free DNA Versus Tissues Biopsy in NSCLC (Non-small Cell Lung Cancer).
ClinicalTrials.gov study NCT03562819. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Doxorubicin-loaded Anti-EGFR-immunoliposomes (C225-ILs-dox) in High-grade Gliomas
ClinicalTrials.gov study NCT03603379. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
ClinicalTrials.gov study NCT04429542. IPD Sharing: NO. Countries: 3. Publications: 0.
Erlotinib as Neoadjuvant Treatment in Patients With Stage ⅢA N2 NSCLC With Activating EGFR Mutation.
ClinicalTrials.gov study NCT01217619. IPD Sharing: Not stated. Countries: 1. Publications: 2.
AST2818 in Advanced Non-Small Cell Lung Cancer With EGFR Mutations
ClinicalTrials.gov study NCT03127449. IPD Sharing: NO. Countries: 1. Publications: 1.
Erlotinib Versus Gemcitabine/Carboplatin in Chemo-naive Stage IIIB/IV Non-Small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor (EGFR) Exon 19 or 21 Mutation
ClinicalTrials.gov study NCT00874419. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Icotinib as Adjuvant Therapy Compared With Standard Chemotherapy in Stage II-IIIA NSCLC With EGFR-mutation
ClinicalTrials.gov study NCT02448797. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Analysis of Re-biopsy Specimens in Advanced NSCLC With Acquired Resistance of EGFR-TKI Targeted Therapy
ClinicalTrials.gov study NCT03309462. IPD Sharing: NO. Countries: 1. Publications: 1.
Study of Lapatinib in Breast Cancer Patients With HER-2 Non-amplified Primary Tumors and HER-2 Positive or EGFR Positive Circulating Tumor Cells
ClinicalTrials.gov study NCT00820924. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Clinical Study of Combination Therapy With Ectiecinib, Pemetrexed and Platinum in Patients With Metastatic Non-squamous Non-small Cell Lung Cancer With EGFR Mutations.
ClinicalTrials.gov study NCT03992885. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Z650 in Advanced Esophageal Squamous Cell Carcinoma With EGFR Over Expression or Gene Amplification
ClinicalTrials.gov study NCT03888092. IPD Sharing: NO. Countries: 1. Publications: 1.
Combination of Osimertinib and Aspirin to Treat 1st Generation EGFR-TKI Resistance in NSCLC
ClinicalTrials.gov study NCT03543683. IPD Sharing: NO. Countries: 1. Publications: 6.
Evaluation of Postmortem Pulmonary Interstitial Fibrosis Severity and EGFR Positivity in Covid-19 Pneumonia
ClinicalTrials.gov study NCT05290441. IPD Sharing: UNDECIDED. Countries: 1. Publications: 3.
the Efficacy and Safety of Anlotinib Combined With Almonertinib in the First-line Treatment of Patients With Brain Metastases From EGFR Mutation-positive Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT04978753. IPD Sharing: NO. Countries: 1. Publications: 1.
Lazertinib for Patients With NSCLC Harboring Uncommon EGFR Mutations
ClinicalTrials.gov study NCT05277701. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Chemotherapy Sequenced by or Combined With EGFR-TKIs for NSCLC Patients Failed to EGFR-TKIs Therapy
ClinicalTrials.gov study NCT01746277. IPD Sharing: Not stated. Countries: 1. Publications: 4.
REZILIENT3 (REsearching ZIpaLertinib In Egfr Non-small Cell Lung Cancer Tumors)
ClinicalTrials.gov study NCT05973773. IPD Sharing: Not stated. Countries: 23. Publications: 1.
Almonertinib Plus Chemotherapy as First-line Treatment in Patients With EGFR Concomitant Tumor Suppressor Gene Mutation
ClinicalTrials.gov study NCT04500717. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.